AVVAA World Health Care Products, Inc.
AVVH · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -19.74% | -6.03% | 0.00% | 0.00% |
| EV / EBITDA | 211.18 | -732.98 | -4,723.82 | 0.00 |
| Quality | ||||
| ROIC | 2.29% | -2.68% | -0.33% | 0.00% |
| Gross Margin | 0.00% | 32.71% | 0.00% | 0.00% |
| Cash Conversion Ratio | -107.60 | 31.82 | 0.88 | 1.41 |
| Growth | ||||
| Revenue 3-Year CAGR | 82.13% | -32.25% | -100.00% | -100.00% |
| Free Cash Flow Growth | -162.04% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 45.48 | -42.54 | 1.89 | 0.00 |
| Interest Coverage | 1.44 | -3.25 | -0.33 | -49.41 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -459.15 | 0.00 | 0.00 |